Namir joined Saba IP in 2012 and is a Shareholder and the Regional Head of the Patent Department at the Head Office. He works alongside a team of technical experts with various backgrounds and provides technical and legal support to all Saba IP branch offices. Namir and his team manage several key patent portfolios—from pre-filing recommendations and strategy through prosecution and grant. He attends IP conferences regularly and has presented at several, including AIPLA, BIO, and GPCA. Namir is the author of a number of patent-related articles on the MENA region, published on blogs, the firm’s website, Managing IP, and The Patent Lawyer.
Before joining Saba IP, Namir worked in the pharmaceuticals industry. He held various roles of increasing responsibility in R&D and later on the corporate side as Alliance Manager, where he managed portfolios with Genzyme (now Sanofi), Eli Lilly, Abbott, and others. During his tenure at Ionis Pharmaceuticals in San Diego, CA, he co-authored several articles published in peer-reviewed scientific journals and was a co-inventor on several patents. His technical background includes pharmaceuticals, RNAs, protein binding, PK/PD, and various therapeutic areas including cardiovascular, oncology, inflammatory, neurodegenerative, and rare diseases.
Namir holds an undergraduate degree in biochemistry from the University of California, Los Angeles, a graduate degree in chemistry from the University of California, Santa Barbara, and an executive MBA from the American University of Beirut. He is a member of FICPI and APPIMAF.
